A Phase 1/2 , Open-Label Safety Pharmacokinetic and Efficacy Stydy of TAS4464 in Patients with Multiple Myeloma or Lymphoma

Type of Cancer
Lymphoma, Multiple Myeloma

Site
Bethesda

Protocol Number
TAS4464-101

To Learn More Call
201-510-0910